EVALUATION OF PARACETAMOL TABLET FORMULATED WITH CO-PROCESSED EXCIPIENT

Student: Vivian Chinonye Eze
Supervisor: Dr Chris Alalor
HOD: Prof Magnus Iwuagwu
Department of Pharmacy
Pharmacy
Madonna University, Elele, Rivers State

Abstract

ABSTRACT A great number of pharmaceutical excipients, both natural and synthetic including the co-processed excipient are available to meet demands of the rapid development of pharmaceutical industry. The aim of this present study is to develop a novel multifunctional pharmaceutical excipient for direct compression (DC) of paracetamol. Methods: The novel excipient was prepared by coprocessing Microcrystalline cellulose, Dibasic calcium phosphate and calcium carbonate into granules using wet granulation . DC was applied in preparing different batches of paracetamol tablets with drug excipient. Both the blended mixture of paracetamol and the excipient powder and the tablets formulated were evaluated for their physicochemical properties including bulk, tapped and particle densities, Hausner's ratio, Carr's index, angle of repose, flow rate, while the tablets formulated were evaluated for uniformity of weight, hardness, friability, disintegration time. The Results: The blended mixture of the co-processed novel excipient and paracetamol mixture exhibited excellent flow property. Formulated tablets were of good quality with regard to weight,friability, hardness, and disintegration time. Conclusion: The paracetamol tablets developed in this study was found to be a promising directly compressible.

Full-Text Access Notice

In accordance with the NERD Policy on promoting peer-reviewed publication, public access to the full text of a project, thesis or dissertation is restricted for three years, allowing the author and supervisors sufficient time to pursue peer-reviewed publication. During this period, researchers with legitimate academic or research purposes may request authorisation directly from the author to enable NERD to release the indexed full texts of the work using the form below.

Request authorisation from the author